(SHC) Sotera Health - Ratings and Ratios

Sotera Health Company (NASDAQ:SHC) is a leading provider of critical sterilization, lab testing, and advisory services, operating across the United States and internationally. The company is structured into three core business segments: Sterigenics, Nordion, and Nelson Labs. Its sterilization offerings include gamma irradiation, electron beam processing, and ethylene oxide sterilization, all of which are essential for ensuring the safety and integrity of medical devices, pharmaceutical products, and other sensitive materials. Additionally, the company designs and maintains gamma irradiation systems, providing end-to-end solutions for its clients.

The company also offers a range of microbiological and analytical chemistry testing services, complemented by technical assistance, regulatory consulting, and advisory services. These services are critical for industries such as medical devices, pharmaceuticals, food safety, agricultural products, and cancer treatment. Beyond healthcare, Sotera serves high-performance materials, commercial, and specialty applications, highlighting the breadth of its expertise and the versatility of its offerings.

Formerly known as Sotera Health Topco, Inc., the company rebranded as Sotera Health Company in October 2020. It was incorporated in 2015 and is headquartered in Broadview Heights, Ohio. With a market capitalization of approximately $3.863 billion, Sotera operates at scale, providing mission-critical services to a diverse array of industries. Its financial metrics, including a P/E ratio of 54.56 and a forward P/E of 17.04, reflect its growth trajectory and market position. The company trades on the NASDAQ under the ticker symbol SHC and is classified under the Life Sciences Tools & Services sub-industry.